BeiGene Ltd (BGNE)
194.56
+0.30
(+0.15%)
USD |
NASDAQ |
Nov 21, 16:00
194.76
+0.20
(+0.10%)
After-Hours: 20:00
BeiGene Debt to Equity Ratio: 0.306 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.306 |
| June 30, 2024 | 0.308 |
| March 31, 2024 | 0.3053 |
| December 31, 2023 | 0.2505 |
| September 30, 2023 | 0.1411 |
| June 30, 2023 | 0.1655 |
| March 31, 2023 | 0.1174 |
| December 31, 2022 | 0.1228 |
| September 30, 2022 | 0.1395 |
| June 30, 2022 | 0.1067 |
| March 31, 2022 | 0.1035 |
| December 31, 2021 | 0.1027 |
| September 30, 2021 | 0.1916 |
| June 30, 2021 | 0.1746 |
| March 31, 2021 | 0.1494 |
| December 31, 2020 | 0.134 |
| September 30, 2020 | 0.0471 |
| June 30, 2020 | 0.1253 |
| March 31, 2020 | 0.0891 |
| December 31, 2019 | 0.2501 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.20 |
| June 30, 2019 | 0.1593 |
| March 31, 2019 | 0.1502 |
| December 31, 2018 | 0.1141 |
| September 30, 2018 | 0.0995 |
| June 30, 2018 | 0.1729 |
| March 31, 2018 | 0.1292 |
| December 31, 2017 | 0.2459 |
| September 30, 2017 | 0.2111 |
| June 30, 2017 | 0.5972 |
| March 31, 2017 | 0.0645 |
| December 31, 2016 | 0.049 |
| September 30, 2016 | 0.096 |
| June 30, 2016 | 0.048 |
| March 31, 2016 | 0.0256 |
| December 31, 2015 | 0.2797 |
| September 30, 2015 | 0.2061 |
| June 30, 2015 | 0.1278 |
| March 31, 2015 | |
| December 31, 2014 | 0.537 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0471
Minimum
Sep 2020
0.308
Maximum
Jun 2024
0.1665
Average
0.1403
Median
Debt to Equity Ratio Benchmarks
| Theravance Biopharma Inc | 0.00 |
| Merck & Co Inc | 0.8568 |
| Bristol-Myers Squibb Co | 2.902 |
| Zai Lab Ltd | 0.1692 |
| Halozyme Therapeutics Inc | 3.323 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.831B |
| Total Liabilities (Quarterly) | 2.395B |
| Shareholders Equity (Quarterly) | 3.436B |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | -0.35% |